Scaffolding Supports the Hippo

Overview

Journal Cell Mol Gastroenterol Hepatol

Specialty Gastroenterology

Date 2024 Jun 7

PMID 38848765

Authors

Mariana Acuna

Affiliations

Soon will be listed here.

References

Ye S, Lawlor M, Rivera-Reyes A, Egolf S, Chor S, Pak K . YAP1-Mediated Suppression of USP31 Enhances NFκB Activity to Promote Sarcomagenesis. Cancer Res. 2018; 78(10):2705-2720. PMC: 6314302. DOI: 10.1158/0008-5472.CAN-17-4052. View

Pfeifer G, Dammann R, Tommasi S . RASSF proteins. Curr Biol. 2011; 20(8):R344-5. DOI: 10.1016/j.cub.2010.02.019. View

Han Y, Dong Q, Hao J, Fu L, Han X, Zheng X . RASSF4 is downregulated in nonsmall cell lung cancer and inhibits cancer cell proliferation and invasion. Tumour Biol. 2015; 37(4):4865-71. DOI: 10.1007/s13277-015-4343-9. View

Liao Y, Zhou C, Duan Y, Liu X, Yue J, Li X . Liver sinusoidal endothelial S1pr2 regulates experimental liver fibrosis through YAP/TGF-β signaling pathway. FASEB J. 2023; 37(5):e22905. DOI: 10.1096/fj.202201954R. View

Russell J, Camargo F . Hippo signalling in the liver: role in development, regeneration and disease. Nat Rev Gastroenterol Hepatol. 2022; 19(5):297-312. PMC: 9199961. DOI: 10.1038/s41575-021-00571-w. View

Eckfeld K, Hesson L, Vos M, Bieche I, Latif F, Clark G . RASSF4/AD037 is a potential ras effector/tumor suppressor of the RASSF family. Cancer Res. 2004; 64(23):8688-93. DOI: 10.1158/0008-5472.CAN-04-2065. View

De Smedt E, Maes K, Verhulst S, Lui H, Kassambara A, Maes A . Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant Progression. Cancer Res. 2017; 78(5):1155-1168. DOI: 10.1158/0008-5472.CAN-17-1544. View

Vaidyanathan S, Salmi T, Sathiqu R, McConville M, Cox A, Brown K . YAP regulates an SGK1/mTORC1/SREBP-dependent lipogenic program to support proliferation and tissue growth. Dev Cell. 2022; 57(6):719-731.e8. DOI: 10.1016/j.devcel.2022.02.004. View

Liu A, Xu X, Hou R, Badawy S, Tao Y, Chen D . DNA methylation and RASSF4 expression are involved in T-2 toxin-induced hepatotoxicity. Toxicology. 2019; 425:152246. DOI: 10.1016/j.tox.2019.152246. View

10.

Lin Y, Deel M, Linardic C . RASSF4 is required for skeletal muscle differentiation. Cell Biol Int. 2019; 44(2):381-390. PMC: 6980882. DOI: 10.1002/cbin.11238. View

11.

Iwasa H, Hossain S, Hata Y . Tumor suppressor C-RASSF proteins. Cell Mol Life Sci. 2018; 75(10):1773-1787. PMC: 11105443. DOI: 10.1007/s00018-018-2756-5. View

12.

Wang X, Zheng Z, Caviglia J, Corey K, Herfel T, Cai B . Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis. Cell Metab. 2017; 24(6):848-862. PMC: 5226184. DOI: 10.1016/j.cmet.2016.09.016. View

13.

Grannas K, Arngarden L, Lonn P, Mazurkiewicz M, Blokzijl A, Zieba A . Crosstalk between Hippo and TGFβ: Subcellular Localization of YAP/TAZ/Smad Complexes. J Mol Biol. 2015; 427(21):3407-15. DOI: 10.1016/j.jmb.2015.04.015. View

14.

Shu Z, Gao Y, Zhang G, Zhou Y, Cao J, Wan D . A functional interaction between Hippo-YAP signalling and SREBPs mediates hepatic steatosis in diabetic mice. J Cell Mol Med. 2019; 23(5):3616-3628. PMC: 6484311. DOI: 10.1111/jcmm.14262. View

15.

Xu C, Fang T, Qu J, Miao Y, Tian L, Zhang M . RASSF4 Attenuates Metabolic Dysfunction-Associated Steatotic Liver Disease Progression via Hippo Signaling and Suppresses Hepatocarcinogenesis. Cell Mol Gastroenterol Hepatol. 2024; 18(2):101348. PMC: 11217689. DOI: 10.1016/j.jcmgh.2024.04.005. View

16.

Varelas X, Samavarchi-Tehrani P, Narimatsu M, Weiss A, Cockburn K, Larsen B . The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-β-SMAD pathway. Dev Cell. 2010; 19(6):831-44. DOI: 10.1016/j.devcel.2010.11.012. View

17.

Nishio M, Sugimachi K, Goto H, Wang J, Morikawa T, Miyachi Y . Dysregulated YAP1/TAZ and TGF-β signaling mediate hepatocarcinogenesis in Mob1a/1b-deficient mice. Proc Natl Acad Sci U S A. 2015; 113(1):E71-80. PMC: 4711826. DOI: 10.1073/pnas.1517188113. View